PharmacoEconomics, 1170-7690

Journal

1 - 10 out of 28Page size: 10

Publications

  1. 2019
  2. E-pub ahead of print

    Early economic evaluation to identify the necessary test characteristics of a new typhoid test to be cost-effective in Ghana

    Frempong, S., Andrew Sutton, Clare Davenport & Pelham Barton, 3 Aug 2019, In : PharmacoEconomics.

    Research output: Contribution to journal › Article

  3. 2018
  4. Published

    Uterotonic drugs for the prevention of postpartum haemorrhage: a cost-effectiveness analysis

    Karen Pickering, Ioannis Gallos, Williams, H., Malcolm Price, Abigail Merriel, David Lissauer, Aurelio Tobias Garces, Hofmeyr, G. J., Arri Coomarasamy & Tracy Roberts, 30 Nov 2018, In : PharmacoEconomics. p. 1-14

    Research output: Contribution to journal › Article

  5. Published

    Understanding and identifying key issues with the involvement of clinicians in the development of decision-analytic model structures: A qualitative study

    Husbands, S., Sue Jowett, Pelham Barton & Coast, J., 7 Aug 2018, In : PharmacoEconomics. p. 1-10 10 p.

    Research output: Contribution to journal › Article

  6. Accepted/In press

    Close person spill-overs in end of life care: using hierarchical mapping to identify whose outcomes to include in economic evaluation

    Canaway, A., Hareth Al-Janabi, Philip Kinghorn, Cara Bailey & Coast, J., 2 Aug 2018, (Accepted/In press) In : PharmacoEconomics.

    Research output: Contribution to journal › Article

  7. 2017
  8. E-pub ahead of print

    Mapping the Paediatric Quality of Life Inventory (PedsQL™) Generic Core Scales onto the Child Health Utility Index–9 Dimension (CHU-9D) Score for Economic Evaluation in Children

    Tosin Lambe, Emma Frew, Natalie Rowland, Rebecca Woolley, Carole Cummins, Brettell, E., Barsoum, E. & Webb, N. J. A., 20 Dec 2017, In : PharmacoEconomics. 29 p.

    Research output: Contribution to journal › Article

  9. Published

    Cost effectiveness of support for people starting a new medication for a long-term condition through community pharmacies: an economic evaluation of the new medicine service (NMS) compared with normal practice

    Elliott, R. A., Tanajewski, L., Gkountouras, G., Avery, A. J., Barber, N., Raj Mehta, Boyd, M. J., Latif, A., Chuter, A. & Justin Waring, Dec 2017, In : PharmacoEconomics. 35, 12, p. 1237-1255 19 p.

    Research output: Contribution to journal › Article

  10. Published

    How qualitative methods can be used to inform model development

    Husbands, S., Sue Jowett, Pelham Barton & Coast, J., Jun 2017, In : PharmacoEconomics. 35, 6, p. 607-612

    Research output: Contribution to journal › Article

  11. 2016
  12. Published

    Complex Valuation: Applying ideas from the complex intervention framework to valuation of a new measure for end of life care

    Jo Coast, Huynh, E., Philip Kinghorn & Flynn, T., May 2016, In : PharmacoEconomics. 34, 5, p. 499-508

    Research output: Contribution to journal › Article

  13. E-pub ahead of print

    Economic evaluation of childhood obesity interventions: reflections and suggestions

    Emma Frew, 11 Mar 2016, In : PharmacoEconomics. 34, 8, p. 733-740

    Research output: Contribution to journal › Article

  14. 2015
  15. Published

    Exploring the use of cost-benefit analysis to compare pharmaceutical treatments for menorrhagia

    Sabina Sanghera, Emma Frew, Janesh Gupta, Kai, J. & Tracy Roberts, Sep 2015, In : PharmacoEconomics. 33, 9, p. 957-965 9 p.

    Research output: Contribution to journal › Article

Previous 1 2 3 Next